A study in the current issue of the Journal of Orthopedic Trauma links Merck’s osteoporosis drug Fosamax to a rare type of fracture in the femur. The small, observational study looked at 70 patients who experienced low-energy femur fractures, which occur when someone falls from a standing height or less. Twenty-five patients (36%) were taking Fosamax on average for four years or more. The Fosam